ChartRow logo
Data provided bySource: Twelve Data
MOH
$209.49-0.17%
as of close, Nov 13, 2026
☾ AH $209.49 -0.17%
PeersCNCHUMELVCICVSUNH
Share this page

MOH financial statements

The full income statement, balance sheet, and cash-flow statement for Molina Healthcare Inc (MOH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +18.5%10Y CAGR +12.3%YoY −3.4%
$44.1B TTM$11.1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +19.1%10Y CAGR +14.5%YoY −4.9%
$5.6B TTM$1.4B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR −6.2%10Y CAGR +7.3%YoY −22.6%
$172M TTM$106M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR −6.8%10Y CAGR +12.7%YoY −51.9%
−$48M TTM$38M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR −4.5%10Y CAGR +13.2%YoY −51.7%
−$0.94 TTM$0.73 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y n/m10Y n/mYoY n/m
$331M TTM−$159M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +6.4%10Y CAGR −2.6%YoY −2.6%
$93M TTM$37M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y n/m10Y n/mYoY n/m
$238M TTM−$196M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −11.7%10Y −5.5%YoY −1.9%
51.1M TTM51.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every MOH chart on Trends →

Shares outstanding (point-in-time)

2024-09 57.2M2024-12 55.5M2025-03 54.2M2025-06 54.2M2025-09 51.4M2025-12 51.5M2026-03 52.1M2026-06 52.2M2026-09 52.2M-8.7% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue45.4B+11.7%40.6B+19.3%34.1B+6.6%32.0B+15.1%27.8B+43.0%
5.94B-4.6%6.22B+15.2%5.40B+12.6%4.80B+18.0%4.07B+64.1%
Cost of revenue39.5B+14.7%34.4B+20.1%28.7B+5.5%27.2B+14.6%23.7B+49.8%
Selling, general & administrative3.01B+9.7%2.74B+11.4%2.46B+6.5%2.31B+11.8%2.07B+39.7%
General & administrative3.01B+9.7%2.74B+11.4%2.46B+6.5%2.31B+11.8%2.07B+39.7%
Amortization of intangibles91.0M+11.0%82.0M-3.5%85.0M+10.4%77.0M+57.1%49.0M+226.7%
Operating income781M-54.2%1.71B+8.5%1.57B+34.1%1.17B+15.0%1.02B-5.4%
Interest expense192M+62.7%118M+8.3%109M-0.9%110M-8.3%120M+17.6%
Interest & investment income———75.0M-2.6%77.0M+352.9%
Other non-operating income——0.000.00+100.0%-25.0M-66.7%
Pre-tax income589M-62.9%1.59B+8.5%1.46B+37.7%1.06B+21.5%875M-8.9%
Income tax117M-71.5%410M+9.9%373M+37.6%271M+25.5%216M-25.0%
472M-60.0%1.18B+8.1%1.09B+37.8%792M+20.2%659M-2.1%
Net income to common472M-60.0%1.18B+8.1%1.09B+37.8%792M+20.2%659M-2.1%
$8.92-56.3%$20.42+8.8%$18.77+38.5%$13.55+20.4%$11.25+0.2%
EPS (basic)$8.93-56.5%$20.52+8.5%$18.91+37.8%$13.72+20.4%$11.40+0.0%
Weighted-avg shares (basic)52.8M-8.0%57.4M-0.5%57.7M-0.2%57.8M+0.0%57.8M-2.0%
Weighted-avg shares (diluted)52.9M-8.3%57.7M-0.7%58.1M-0.7%58.5M-0.2%58.6M-2.2%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
12.4B-2.6%12.8B+1.8%12.5B+24.4%10.1B+0.2%10.1B+27.8%
Cash & equivalents4.25B-8.9%4.66B-3.8%4.85B+21.0%4.01B-9.7%4.44B+6.8%
Short-term investments4.01B-7.3%4.33B+1.5%4.26B+21.7%3.50B+9.3%3.20B+70.8%
Accounts receivable3.53B+7.1%3.30B+6.3%3.10B+34.8%2.30B+5.7%2.18B+30.2%
Prepaid expenses655M+34.5%487M+47.1%331M+19.5%277M+12.1%247M+41.1%
15.6B-0.4%15.6B+5.0%14.9B+20.9%12.3B+0.9%12.2B+28.1%
Operating lease right-of-use30.0M-14.3%35.0M——128M+80.3%
Goodwill1.96B+17.2%1.67B+34.6%1.24B+11.3%1.11B+13.5%982M+41.9%
Intangible assets237M-11.2%267M+28.4%208M-24.4%275M+1.9%270M+8.4%
Deferred tax assets178M-14.0%207M-8.8%227M+3.2%220M+107.5%106M+53.6%
Other non-current assets147M+6.5%138M-3.5%143M+16.3%123M-31.3%179M+50.4%
7.37B-6.6%7.90B-3.3%8.17B+19.2%6.86B-2.7%7.05B+41.9%
Accrued liabilities1.09B-17.9%1.33B+6.3%1.25B+40.8%889M+5.6%842M+31.4%
Deferred revenue66.0M+29.4%51.0M-87.8%418M+16.4%359M-3.0%370M-1.3%
Current lease liability15.0M+0.0%15.0M-25.0%20.0M-51.2%41.0M+17.1%35.0M+66.7%
Finance lease liability (current)25.0M+8.7%23.0M+9.5%21.0M-4.5%22.0M+46.7%15.0M+25.0%
11.5B+3.2%11.1B+4.3%10.7B+14.2%9.35B-2.4%9.58B+28.8%
Long-term debt3.77B+28.8%2.92B+34.1%2.18B+0.2%2.18B+0.1%2.17B+2.2%
Non-current lease liability56.0M-17.6%68.0M-20.0%85.0M+10.4%77.0M-22.2%99.0M+135.7%
Operating lease liability (total)71.0M-14.5%83.0M-21.0%105M-11.0%118M-11.9%134M+76.3%
Finance lease liability (total)209M-4.1%218M-3.5%226M-4.6%237M+1.3%234M-1.3%
Finance lease liability184M-5.6%195M-4.9%205M-4.7%215M-1.8%219M-2.7%
Other non-current liabilities173M+44.2%120M-3.2%124M+19.2%104M-25.7%140M+17.6%
4.07B-9.5%4.50B+6.7%4.21B+42.2%2.96B+12.7%2.63B+25.5%
Preferred stock0.000.000.000.000.00
Additional paid-in capital452M-2.2%462M+12.7%410M+25.0%328M+39.0%236M+18.6%
Retained earnings3.60B-12.0%4.09B+5.2%3.89B+39.0%2.80B+16.5%2.40B+29.0%
Accumulated other comprehensive income15.0M+126.3%-57.0M+30.5%-82.0M+48.8%-160M-3100.0%-5.00M-113.5%
Total equity incl. non-controlling4.07B-9.5%4.50B+6.7%4.21B+42.2%2.96B+12.7%2.63B+25.5%
Total liabilities & equity15.6B-0.4%15.6B+5.0%14.9B+20.9%12.3B+0.9%12.2B+28.1%
Common shares outstanding51.0M-8.9%56.0M-3.4%58.0M+0.0%58.0M+0.0%58.0M-1.7%
Shares outstanding (cover)51.5M-7.2%55.5M-5.0%58.4M+0.9%57.9M-0.9%58.4M+0.7%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-535M-183.1%644M-61.3%1.66B+115.0%773M-63.5%2.12B+11.6%
Depreciation & amortization195M+4.8%186M+8.8%171M-2.8%176M+34.4%131M+48.9%
Intangible amortization91.0M+11.0%82.0M-3.5%85.0M+10.4%77.0M+57.1%49.0M+226.7%
Share-based compensation47.0M-59.5%116M+0.9%115M+11.7%103M+43.1%72.0M+26.3%
Deferred income taxes43.0M-18.9%53.0M+271.0%-31.0M+53.0%-66.0M-175.0%-24.0M-26.3%
Other operating activities-3.00M-137.5%8.00M+300.0%2.00M-75.0%8.00M-75.8%33.0M+175.0%
312M+167.2%-464M+37.6%-744M+5.8%-790M+52.2%-1.65B-313.3%
Capital expenditure101M+1.0%100M+19.0%84.0M-7.7%91.0M+18.2%77.0M+4.1%
Free cash flow-636M-216.9%544M-65.5%1.58B+131.4%682M-66.6%2.04B+12.0%
Acquisitions245M-28.8%344M+11366.7%3.00M-97.8%134M+3.9%129M-82.9%
Other investing activities-1.00M+0.0%-1.00M+75.0%-4.00M-108.0%50.0M-20.6%63.0M+3250.0%
-170M+51.0%-347M-498.3%-58.0M+86.8%-441M-141.0%-183M-184.3%
Long-term debt issued838M+13.2%740M0.000.00-100.0%740M-48.2%
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased1.00B+0.0%1.00B0.00-100.0%400M+212.5%128M-78.9%
Dividends paid0.000.000.000.000.00
Other financing activities29.0M+196.7%-30.0M-1600.0%2.00M-93.9%33.0M+3200.0%1.00M-50.0%
Net change in cash-393M-135.3%-167M-119.4%860M+287.8%-458M-261.8%283M-83.5%
Interest paid181M+49.6%121M+12.0%108M+0.0%108M-15.0%127M+13.4%
Income taxes paid275M-27.4%379M-6.4%405M+19.1%340M+44.7%235M-26.8%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap8.85B-45.7%16.3B-22.6%21.1B+9.2%19.3B+4.5%18.4B+47.0%
P/E18.8×+35.6%13.8×-38.9%22.6×-1.6%23.0×-17.9%28.0×+50.1%
P/S0.2×-51.4%0.4×-36.7%0.6×+2.4%0.6×-6.8%0.7×+2.8%
P/B2.2×-40.0%3.6×-33.2%5.4×-14.4%6.3×-9.6%7.0×+17.2%
P/FCF—30.0×+190.3%10.3×-20.8%13.0×+44.2%9.0×+31.3%
Earnings yield5.3%-26.3%7.2%+63.7%4.4%+1.6%4.4%+21.8%3.6%-33.4%
FCF yield—3.3%-65.6%9.7%+26.3%7.7%-30.7%11.1%-23.9%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025Joseph Zubretsky$18.3M−$15.3M$5.1M$81.60$161.89
FY2024—$21.9M$15.4M$5.4M$136.85$150.36
FY2023—$21.5M$25.2M$4.7M$169.88$142.64
FY2022—$22.1M$41.7M$5.4M$155.27$140.31
FY2021—$20M$75.9M$4.2M$149.56$129.09
FY2020—$17.8M$58.2M$4.4M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: MOH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MOH filings on SEC EDGAR → Not investment advice.